• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

by March 14, 2025
written by March 14, 2025

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Dollar General CEO warns consumers are cash-strapped and says 2025 won’t be better
next post
Senate to take up Trump spending bill as clock ticks down to government shutdown

related articles

Hawley blasts FDA approval of new abortion drug,...

October 2, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 2, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 2, 2025

The agency staff Vought might recommend cutting and...

October 2, 2025

Reagan-appointed judge, once rebuked by Supreme Court, continues...

October 2, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 2, 2025

Trump must triple severely outdated nuke arsenal to...

October 2, 2025

White House says federal layoffs could hit ‘thousands’...

October 2, 2025

Johnson shuts door on negotiating shutdown deal as...

October 2, 2025

Democrats refuse to budge over Obamacare fight as...

October 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • ‘Make Bitcoin Great Again’: Trump and GOP’s presence looms over annual crypto gathering

    July 29, 2024
  • Trans inmate’s lawsuit challenges Trump ‘two-sexes’ order cutting off tax money for gender therapy

    January 28, 2025
  • Trump’s ‘they/them’ ads combined culture war, economic worries to make effective pitch: expert

    November 8, 2024
  • SafeMoon and Litecoin: Litecoin retreating to a new low

    August 21, 2024
  • Trump admin cracks down on groups tied to Iran targeting US citizens, sanctions Iranian-linked Swedish gang

    March 14, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,247)
  • Investing (634)
  • Stock (935)

Latest Posts

  • Nancy Pelosi claims Dem primary process was ‘open’ and Kamala Harris ‘won it’

    September 19, 2024
  • Apple boosts U.S. investment plans with $500 billion pledge amid Trump tariff threat

    February 24, 2025
  • Trump nominates Susan Monarez to become the next CDC director, says Americans ‘lost confidence’ in agency

    March 25, 2025

Recent Posts

  • Senate to hold final vote on RFK Jr nomination to serve as Trump’s Health secretary

    February 13, 2025
  • Titan X Crypto: Latest Updates & How to Buy TITAN X

    September 3, 2024
  • LimeWire acquires Fyre Festival, asking ‘What Could Possibly Go Wrong?’

    September 17, 2025

Editor’s Pick

  • FCC is investigating Disney and ABC for DEI initiatives

    March 29, 2025
  • Senate GOP agree to strip cuts to HIV, AIDS prevention program from Trump’s clawback bill

    July 15, 2025
  • Steve Bannon warns of world conflict that could be ‘Trump’s Vietnam’

    January 20, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock